IL-6 Antikörper
Kurzübersicht für IL-6 Antikörper (ABIN1383946)
Target
Alle IL-6 (IL6) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Recognises both natural and recombinant human IL-6
-
Aufreinigung
- Ion exchange chromatography
-
Sterilität
- 0.22 μm filtered
-
Immunogen
- Recombinant human IL-6,Myeloma X63/AG.8653 x Balb/c spleen cells
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
-
Konservierungsmittel
- Without preservative
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
-
-
-
: "STAT3 is constitutively activated in Hodgkin cell lines." in: Blood, Vol. 98, Issue 3, pp. 762-70, (2001) (PubMed).
: "Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors." in: Cancer research, Vol. 56, Issue 23, pp. 5499-505, (1997) (PubMed).
: "Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies." in: European journal of immunology, Vol. 25, Issue 12, pp. 3474-81, (1996) (PubMed).
: "Immunodetection of histone epitopes correlates with early stages of apoptosis in activated human peripheral T lymphocytes." in: The American journal of pathology, Vol. 149, Issue 2, pp. 653-63, (1996) (PubMed).
: "Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodies." in: Molecular immunology, Vol. 28, Issue 11, pp. 1183-92, (1992) (PubMed).
-
: "STAT3 is constitutively activated in Hodgkin cell lines." in: Blood, Vol. 98, Issue 3, pp. 762-70, (2001) (PubMed).
-
- IL-6 (IL6) (Interleukin 6 (IL6))
-
Andere Bezeichnung
- IL-6
-
Pathways
- TLR Signalweg, Hormone Transport, Negative Regulation of Hormone Secretion, Myometrial Relaxation and Contraction, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Regulation of Carbohydrate Metabolic Process, Autophagie, Cell RedoxHomeostasis, Cancer Immune Checkpoints, Inflammasome
Target
-